CGON
CGON
US1569441009
CG Oncology, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
5.66B EUR
6.27B EUR
5.96B EUR
3.35B EUR
Enterprise Value
4.59B EUR
6.26B EUR
5.93B EUR
3.32B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-21.13x
--
--
--
Price to Sales
908.32x
1,007.41x
1,174.59x
840.07x
Price to Book
5.48x
6.1x
5.46x
4.45x
EV/Revenue
736.66x
1,005.68x
1,169.44x
833.69x
EV/EBITDA
-18.38x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-2.01%
-2.86%
-2.69%
-3.08%
ende